资讯

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biopharmaceutical innovator ...
Looking ahead, the agency said it is working with partners to launch a five-year Lassa Fever Strategic Plan covering 2025 to 2029 ...
On September 16, TINNOVE Wutong Technology held a press conference for the 2025 TTi brand and product launch under the theme ...
The key market opportunities for construction cameras lie in their vital role in project management by offering real-time ...